Literature DB >> 25916559

Experimental study on the role of intra-articular injection of MSCs on cartilage regeneration in haemophilia.

R Ravanbod1, G Torkaman1, M Mophid2, F Mohammadali3.   

Abstract

Mesenchymal stem cells (MSCs) therapy is a field in progress in cartilage repair strategies. We tried to investigate the functional properties of the joint and cartilage in experimental haemarthrosis (EH) after MSCs intra-articular (IA) injection. One millilitre of fresh autologous blood was injected twice a week for three consecutive weeks in three groups including control haemophilia 10 days (n = 8), control haemophilia 38 days (n = 8) and MSCs (n = 8) group. In later, 10 days after the end of IA blood injections, MSCs IA injection was performed. Eight animals received no treatment as the normal control group. Thirty-eight days after the end of IA blood injections, animals were sacrificed. Joint friction and stress-relaxation tests were done, inflammatory cytokines of synovial membrane and scanning electron microscopy of the cartilage assessed. Joint friction decreased in MSCs in comparison to other groups and was significant with normal control group, (P = 0.011). The mechanical properties of cartilage showed no significant differences between groups. Tumour necrosis factor alpha and interleukin 1 beta decreased and IL-4 very slightly increased in MSCs in comparison to the time-matched control group. Scanning electron microscopy enabled acquisition of good structural properties of the surface and layers of the cartilage after MSCs injection. The hole induced in the medial plateau of the tibia bones, after inducing haemarthrosis, were covered with cartilage-like structure. The results showed that MSCs IA injection has some beneficial effects on cartilage structure and function in haemarthrosis model and is promising in patients with haemophilia.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  articular cartilage; biomechanics; friction; haemarthrosis; knee joint; mesenchymal stem cell

Mesh:

Substances:

Year:  2015        PMID: 25916559     DOI: 10.1111/hae.12659

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  1 in total

1.  Endothelial cells derived from patients' induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A.

Authors:  Melanie Rose; Kewa Gao; Elizabeth Cortez-Toledo; Emmanuel Agu; Alicia A Hyllen; Kelsey Conroy; Guangjin Pan; Jan A Nolta; Aijun Wang; Ping Zhou
Journal:  Stem Cells Transl Med       Date:  2020-03-12       Impact factor: 6.940

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.